XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock and Stock-Based Incentive Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Common Shares Outstanding Shares of common stock outstanding were as follows:
Year Ended
December 31,
2022
December 25,
2021
December 26,
2020
(In millions)
Balance, beginning of period1,207 1,211 1,170 
Common stock issued in the acquisition of Xilinx429 — — 
Common stock issued under employee equity plans17 12 14 
Repurchases of common stock(36)(17)— 
Common stock repurchases for tax withholding on equity awards(5)(2)(1)
Issuance of common stock to settle convertible debt— 28 
Balance, end of period1,612 1,207 1,211 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Stock-based compensation expense was allocated in the consolidated statements of operations as follows:
Year Ended
December 31, 2022December 25, 2021December 26, 2020
 (In millions)
Cost of sales$29 $$
Research and development697 246 173 
Marketing, general, and administrative355 128 95 
Total stock-based compensation expense before income taxes1,081 379 274 
Income tax benefit(179)(58)(42)
Total stock-based compensation expense, net of income taxes$902 $321 $232 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The weighted-average estimated fair value of employee stock options granted during 2022, 2021 and 2020 was $44.35, $46.07 and $38.49 per share, respectively, using the following assumptions:
December 31, 2022December 25, 2021December 26, 2020
Expected volatility51.28 %51.77 %57.87 %
Risk-free interest rate3.00 %0.69 %0.18 %
Expected dividends— %— %— %
Expected life (in years)4.754.554.30
The weighted-average grant date fair values of PRSUs granted during 2022, 2021 and 2020 were $121.12, $153.89 and $122.95, respectively, using the following assumptions:
December 31, 2022December 25, 2021December 26, 2020
Expected volatility
50.65% - 53.51%
57.75 %
55.74% - 60.10%
Risk-free interest rate
1.14% - 3.17%
0.43 %
0.14% - 1.41%
Expected dividends— %— %— %
Expected term (in years)
2.07 - 3.07
3.00
2.48 - 3.00
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes stock option activity and related information:
Outstanding Number
of Shares
Weighted-
Average
Exercise
Price
Aggregate Intrinsic ValueWeighted-Average Remaining Contractual Life
(in years)
 (In millions, except share price)
Balance as of December 25, 2021$23.98 
Granted$95.54 
Exercised(2)$4.27 
Balance as of December 31, 2022$42.35 $130 3.17
Exercisable December 31, 2022$25.67 $130 2.27
Schedule of Share-based Compensation, Restricted Stock Units, Activity
The following table summarizes time-based RSU activity and related information:
Number
of Shares
Weighted- Average Grant Date Fair ValueAggregate Intrinsic ValueWeighted-Average Remaining Contractual Life
(in years)
 (In millions except share price)
Unvested shares as of December 25, 202110 $79.03 
Assumed with acquisition of Xilinx12 $103.35 
Granted17 $92.92 
Forfeited(2)$98.06 
Vested(9)$86.27 
Unvested shares as of December 31, 202228 $95.49 $1,810 1.67
Schedule of Nonvested Performance-based Units Activity
The following table summarizes PRSU activity and related information:
 Number
of Shares
Weighted-Average
Grant Date Fair Value
Aggregate Intrinsic ValueWeighted-Average Remaining Contractual Life
(in years)
(In millions except share price)
Unvested shares as of December 25, 2021$78.59 
Granted$121.12 
Forfeited— $— 
Vested(1)$51.77 
Unvested shares as of December 31, 2022$110.31 $118 1.76
Schedule of ESPP The weighted-average grant date fair value for the ESPP during 2022, 2021 and 2020 was $24.71, $27.27 and $20.97 per share, respectively, using the following assumptions:
December 31, 2022December 25, 2021December 28, 2020
Expected volatility
58.15% - 63.76%
36.90% - 39.39%
55.16% - 66.53%
Risk-free interest rate
1.43% - 4.52%
0.04% - 0.07%
0.11% - 0.15%
Expected dividends— %— %— %
Expected term (in years)0.500.500.50